Clinical Trial Update: A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients [Phase 1]

View source ↗

Summary

Phase I study evaluating KGX101 as a monotherapy and in combination with Envafolimab in patients with advanced or metastatic solid tumors; recruitment is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Envafolimab (envafolimab)
• KGX101

Snippet

Sponsor: Kangabio AUSTRALIA LTD PTY | Conditions: Advanced or Metastatic Solid Tumors | Phase 1 | Status: RECRUITING